Insiders were net buyers of Apiam Animal Health Limited's (ASX:AHX ) stock during the past year. That is, insiders bought more stock than they sold.

While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.

Check out our latest analysis for Apiam Animal Health

The Last 12 Months Of Insider Transactions At Apiam Animal Health

In the last twelve months, the biggest single purchase by an insider was when MD & Executive Director Christopher Richards bought AU$252k worth of shares at a price of AU$0.85 per share. That implies that an insider found the current price of AU$0.94 per share to be enticing. That means they have been optimistic about the company in the past, though they may have changed their mind. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. The good news for Apiam Animal Health share holders is that an insider was buying at near the current price. The only individual insider to buy over the last year was Christopher Richards.

Christopher Richards bought a total of 392.65k shares over the year at an average price of AU$0.86. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

Apiam Animal Health is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Insider Ownership of Apiam Animal Health

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. Apiam Animal Health insiders own about AU$40m worth of shares. That equates to 31% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

What Might The Insider Transactions At Apiam Animal Health Tell Us?

Insider purchases may have been minimal, in the last three months, but there was no selling at all. Overall the buying isn't worth writing home about. But insiders have shown more of an appetite for the stock, over the last year. Overall we don't see anything to make us think Apiam Animal Health insiders are doubting the company, and they do own shares. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Apiam Animal Health. To assist with this, we've discovered 4 warning signs that you should run your eye over to get a better picture of Apiam Animal Health.

Of course Apiam Animal Health may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.